Eddie Redmayne is in high demand following his Golden Globes win for his acclaimed portrayed of Stephen Hawking in The Theory of Everything. The esteemed actor has chosen another challenging role for his next project, in which he will play the first transgender woman to ever have gender reassignment surgery.
The 33-year-old actor spoke to E! News about the film titled The Danish Girl, which will be a "semi-fictionalised" look at the life of Danish painter Einar Wegener, who later became Lili Elbe after becoming the first man to have sexual reassignment surgery in 1931.
He is approaching the role with the same intensity with which he researched playing Stephen, who was diagnosed with ALS in his early 20s.
“There are many people who have written Ph.D’s on Lili’s story,” Eddie said. “Even though it is period and under completely different circumstances than today, I’m meeting many women from the trans community and hearing their experiences.”
He continued, “I have put on dresses and wigs and make-up. I’m beginning to embark on that and trying to find out who she is.”
It has been an extraordinary few days for Eddie, who found out on Thursday he had been nominated for a Best Actor Oscar for his turn in The Theory Of Everything. “We’re absolutely delighted and over the moon with the news,” his proud mom Patricia said shortly after the announcement was made.
“I found out this afternoon and I had some champagne with some friends to celebrate. I think there are so many great actors out there at the moment, I think he had done so well to be nominated. I’ve spoken to him on the phone and he is just very, very excited.”
Eton-educated Eddie had already been named Best Actor at the Golden Globes 2015 earlier in the week. “Oh my God, what an extraordinary thing,” the overwhelmed star said, as he arrived on stage to accept his coveted trophy.
HELLO! Canada magazine is available for your tablet and smartphone. Get HELLO! Canada, PEOPLE, Vanity Fair and over 100 more of the world’s best magazines for one low monthly price at Next Issue. CLICK HERE to sign up for a free trial.